Shots: The approval is based on P-III HAVEN 3 & HAVEN 4 study assessing Hemlibra in 152 & 48 patients haemophilia A without & with/without factor VIII inhibitors aged > […]readmore
Tags : Factor VIII Inhibitors
Shots: The FDA’s BT designation is based on P-III HAVEN 3 study assessing Hemlibra vs no prophylaxis in 152 patients in ratio (2:2:1) with hemophilia A + prior treated with […]readmore